IGF-1 Mutant Mini-Pig Model for Viable Laron Syndrome Phenotypes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current animal models for Laron syndrome, such as IGF-1 knockout mice and transgenic mini-pigs, fail to exhibit all the phenotypic symptoms of the condition, and existing rodent models show significant anatomical and physiological differences from humans, complicating clinical trials.
Innovation Solution
A recombinant expression vector using CRISPR/Cas9 technology is developed to knockout the IGF-1 gene in mini-pigs, creating a transgenic cell line that, when integrated into a nuclear transfer embryo and implanted into a recipient female, produces a dwarfism animal model with phenotypes resembling Laron syndrome, including prominent forehead, small cranium, truncal obesity, and delayed puberty.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If IGF-1 knockout mice are used as a disease model, then the genetic mutation can be achieved, but the animals die one day after birth due to breathing difficulty
Solution Approach 1:
The patent applies local quality by knocking out the IGF-1 gene specifically in the liver (which produces 75% of IGF-1) rather than systemically throughout the entire organism. This conditional knockout using the Cre/loxp system allows the disease phenotype to be studied while maintaining sufficient IGF-1 in other tissues to support basic survival functions like breathing.
Solution Approach 2:
The patent uses partial action by achieving a 75% or higher decrease in circulating IGF-1 levels through liver-specific knockout, rather than complete systemic knockout. This partial reduction is sufficient to reproduce Laron syndrome phenotypes while avoiding the lethal effects of complete IGF-1 deficiency.
2Ease of manufacture
If rodent models are used for genetic disease studies, then the genetic manipulation is easier, but the pathology and symptoms show significant differences from humans
Solution Approach 1:
The patent changes the species parameter from rodents to pigs, which have anatomical, physiological, and metabolic parameters much closer to humans. Pigs share 98% genetic similarity with humans in many metabolic pathways and have comparable organ sizes and lifespans, making them superior models for translating genetic disease findings to human clinical contexts.
Solution Approach 2:
The patent creates a more accurate copy of human Laron syndrome pathology by using pigs that naturally resemble human physiology. The transgenic pig model reproduces all major phenotypic features of Laron syndrome including dwarfism, obesity, and metabolic abnormalities, providing a faithful copy of human disease presentation.
3Reliability
If transgenic cloned mini-pigs with growth hormone receptor gene knocked out are produced, then some phenotypes like dwarfism and obesity are observed, but not all symptoms of Laron syndrome are exhibited
Solution Approach 1:
The patent extracts and corrects the specific genetic defect by knocking out the IGF-1 gene itself rather than the growth hormone receptor. This directly reproduces the human Laron syndrome genetic mutation, allowing all associated phenotypes including craniofacial abnormalities, dental defects, and metabolic disturbances to manifest naturally without requiring receptor manipulation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The dwarfism animal model accurately mimics Laron syndrome symptoms, overcoming the immediate death issue in IGF-1 knockout mice and providing a closer human-analogous model for drug efficacy and safety testing.
Implementation Method 1
A recombinant expression vector using CRISPR/Cas9 technology is developed to knockout the IGF-1 gene in mini-pigs
Implementation Method 2
forming a nuclear transfer embryo by transferring a transgenic cell line for generating a dwarfism animal model into an enucleated oocyte
Data Source
AI summary
The present disclosure relates to a dwarfism animal model carrying an IGF-1 gene mutation and a method for generating the same. According to the present disclosure, the problem that an animal dies immediately after birth is overcome, the majority of phenotypes seen in Laron syndrome patients may be observed in the dwarfism animal model, and the dwarfism animal model has decreased expression of personality genes. Thus, the dwarfism animal model may be effectively used as a dwarfism-related disease model.